SCHEMBL18615459

SCHEMBL18615459

CC(C)(C)OC(=O)N[C@H]1CC[C@H](Oc2cc(N3CCOCC3)ncn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.47
▸ CKS1B P61024 1/20 0.43
▸ SKP1 P63208 1/20 0.43
▸ SKP2 Q13309 1/20 0.43
▸ CACNB4 O00305 1/20 0.42
▸ CACNA1A O00555 1/20 0.42
▸ CACNA1G O43497 1/20 0.42
▸ CACNG3 O60359 1/20 0.42
▸ CACNA1F O60840 1/20 0.42
▸ CACNA1H O95180 1/20 0.42
▸ CACNB3 P54284 1/20 0.42
▸ CACNA2D1 P54289 1/20 0.42
▸ CACNG7 P62955 1/20 0.42
▸ CACNA1B Q00975 1/20 0.42
▸ CACNA1D Q01668 1/20 0.42
▸ CACNB1 Q02641 1/20 0.42
▸ CACNG1 Q06432 1/20 0.42
▸ CACNB2 Q08289 1/20 0.42
▸ CACNA1S Q13698 1/20 0.42
▸ CACNA1C Q13936 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20357324 0.86 CYP2C19 (0.50) CYP2C19KMORAF1MAPK3MAP2K7
SCHEMBL18615440 0.83 LRRK2 (0.48) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL20357227 0.81 CACNB4 (0.50) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL18616057 0.81 CACNB4 (0.50) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL17085624 0.80 CKS1B (0.53) CYP2C19CKS1BSKP1SKP2MAP4K4
SCHEMBL18615747 0.80 CKS1B (0.43) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL18615424 0.80 CKS1B (0.47) CKS1BSKP1SKP2RAF1MAP4K4
SCHEMBL18616061 0.79 CACNB4 (0.44) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL21187339 0.77 MAP4K4 (0.38) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL29342828 0.76 CKS1B (0.42) CKS1BSKP1SKP2CACNB4CACNA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345893-B1 UREA DERIVATIVE AND USE THEREFOR TORAY INDUSTRIES (JP) 2019-10-30 — — EP disclosed
US-10280145-B2 Urea derivative and use therefor TORAY INDUSTRIES, INC. (JP) 2019-05-07 — — US disclosed
EP-3345893-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 — — EP disclosed
WO-2017038873-A1 UREA DERIVATIVE AND USE THEREFOR 東レ株式会社 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280145-B2 Urea derivative and use therefor UTS2R, DDR1, WEE1 CYP2C19 4354/4885CKS1B 1366/4885SKP1 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback